EMBR Labs Inc. – Trademark Portfolio
Entity Type: 03
EMBR Labs Inc. holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 9 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 5 Nice Classification classes. Currently, 3 trademarks are registered and 2 are pending. Notable registered marks include EMBR, WAVE, and EMBR WAVE. The owner is based in Cambridge, MA.
288 Norfolk Street, Suite 4A
Cambridge, MA 02139
Showing of trademarks Trademarks
Trademark Classifications
EMBR Labs Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Scientific and technological services; industrial analysis and research services
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does EMBR Labs Inc. have?
EMBR Labs Inc. has 11 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending, 6 abandoned.
What trademark classes does EMBR Labs Inc. file in?
EMBR Labs Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 25 (Clothing), Class 36 (Insurance & Financial), Class 14 (Jewelry). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are EMBR Labs Inc.'s most well-known trademarks?
EMBR Labs Inc.'s registered trademark portfolio includes well-known marks such as EMBR, WAVE, and EMBR WAVE. These are among 3 currently registered trademarks in the portfolio.
What is EMBR Labs Inc.'s trademark registration success rate?
EMBR Labs Inc. has a 33% trademark registration rate, with 3 out of 9 resolved applications resulting in successful registration. Currently, 2 applications are pending review.